Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Plos One
|
November 20, 2019
Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients
Valentina Iacuzzi, Bianca Posocco, Martina Zanchetta, et al.
International Journal of Molecular Sciences
|
February 25, 2023
Impact of <i>ABCG2</i> and <i>ABCB1</i> Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis
Chiara Dalle Fratte, Jerry Polesel, Sara Gagno, et al.
Plos One
|
February 8, 2020
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application
Bianca Posocco, Mauro Buzzo, Ariana Soledad Poetto, et al.
Plos One
|
October 26, 2021
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring
Martina Zanchetta, Valentina Iacuzzi, Bianca Posocco, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 21, 2023
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer
Elena Peruzzi, Lorenzo Gerratana, Marcella Montico, et al.
Frontiers in Pharmacology
|
August 9, 2022
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer
Rossana Roncato, Lorenzo Gerratana, Lorenza Palmero, et al.
British Journal of Clinical Pharmacology
|
September 30, 2022
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients
Chiara Dalle Fratte, Sara Gagno, Rossana Roncato, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
October 26, 2021
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer
Ariana Soledad Poetto, Bianca Posocco, Sara Gagno, et al.
International Journal of Molecular Sciences
|
April 14, 2026
LC-MS/MS Method for Therapeutic Drug Monitoring of Abiraterone, Darolutamide, Apalutamide, Enzalutamide, and Metabolites in Prostate Cancer Patients
Bianca Posocco, Diletta Pasin, Nicoletta De Cesaro, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 9, 2023
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure
Rossana Roncato, Elena Peruzzi, Lorenzo Gerratana, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Plos One
|
November 20, 2019
Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients
Valentina Iacuzzi, Bianca Posocco, Martina Zanchetta, et al.
International Journal of Molecular Sciences
|
February 25, 2023
Impact of <i>ABCG2</i> and <i>ABCB1</i> Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis
Chiara Dalle Fratte, Jerry Polesel, Sara Gagno, et al.
Plos One
|
February 8, 2020
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application
Bianca Posocco, Mauro Buzzo, Ariana Soledad Poetto, et al.
Plos One
|
October 26, 2021
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring
Martina Zanchetta, Valentina Iacuzzi, Bianca Posocco, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 21, 2023
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer
Elena Peruzzi, Lorenzo Gerratana, Marcella Montico, et al.
Frontiers in Pharmacology
|
August 9, 2022
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer
Rossana Roncato, Lorenzo Gerratana, Lorenza Palmero, et al.
British Journal of Clinical Pharmacology
|
September 30, 2022
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients
Chiara Dalle Fratte, Sara Gagno, Rossana Roncato, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
October 26, 2021
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer
Ariana Soledad Poetto, Bianca Posocco, Sara Gagno, et al.
International Journal of Molecular Sciences
|
April 14, 2026
LC-MS/MS Method for Therapeutic Drug Monitoring of Abiraterone, Darolutamide, Apalutamide, Enzalutamide, and Metabolites in Prostate Cancer Patients
Bianca Posocco, Diletta Pasin, Nicoletta De Cesaro, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 9, 2023
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure
Rossana Roncato, Elena Peruzzi, Lorenzo Gerratana, et al.
Page
of 5